[1] Devesa SS, Blot WJ, Fraumeni JJ. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States[J]. Cancer, 1998, 83(10): 2049-2053.
[2] Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012[J]. Int J Cancer, 2015, 136(5):E359-E386. DOI: 10.1002/ijc.29210.
[3] Buas MF, Vaughan TL. Epidemiology and risk factors for gastroesophageal junction tumors: understanding the rising incidence of this disease [J]. Semin Radiat Oncol, 2013, 23(1): 3-9. DOI: 10.1016/j.semradonc.2012.09.008.
[4] Yao K, Uedo N, Muto M, et al. Development of an e-learning system for teaching endoscopists how to diagnose early gastric cancer: basic principles for improving early detection [J]. Gastric Cancer, 2017, 20 Suppl 1: 28-38. DOI: 10.1007/s10120-016-0680-7.
[5] Siewert JR, Feith M, Stein HJ. Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: relevance of a topographic-anatomic subclassification [J]. J Surg Oncol, 2005, 90(3): 139-146. DOI: 10.1002/jso.20218.
[6] 杨宏, 武爱文, 季加孚, 等. 食管胃结合部腺癌471例Siewert分型临床研究[J]. 中国实用外科杂志, 2012,32(4): 310-315.
[7] 孙昌裕,邓靖宇,梁寒,等. 303例食管胃结合部腺癌的Siewert分型及临床病理特征和预后因素分析[J]. 中华消化外科杂志,2016,15(11):1068-1074. DOI:10.3760/cma.j.issn.1673-9752.2016.11.007.
[8] 戴萌,熊毅敏,金雷,等. 早期胃食管结合部癌病理学特征的回顾分析[J]. 华南国防医学杂志,2017,31(10):672-675. DOI:10.13730/j.issn.1009-2595.2017.10.007.
[9] Urabe M, Ushiku T, Shinozaki-Ushiku A, et al. Adenocarcinoma of the esophagogastric junction and its background mucosal pathology: a comparative analysis according to Siewert classification in a Japanese cohort [J]. Cancer Med, 2018, 7(10): 5145-5154. DOI: 10.1002/cam4.1763.
[10] Keeney S, Bauer TL. Epidemiology of adenocarcinoma of the esophagogastric junction[J]. Surg Oncol Clin N Am, 2006, 15(4):687-696. DOI: 10.1016/j.soc.2006.07.014.
[11] Deng JY, Liang H. Adenocarcinoma of esophagogastric junction[J]. Chin J Cancer Res, 2014, 26(4): 362-363. DOI: 10.3978/j.issn.1000-9604.2014.07.03.
[12] Siewert JR, Feith M. Adenocarcinoma of the esophagogastric junction: competition between Barrett and gastric cancer[J]. J Am Coll Surg, 2007, 205 4 Suppl: S49-S53. DOI: 10.1016/j.jamcollsurg.2007.06.324.
[13] Felley C, Bouzourene H, VanMelle MB, et al. Age, smoking and overweight contribute to the development of intestinal metaplasia of the cardia [J]. World J Gastroenterol, 2012, 18(17): 2076-2083. DOI: 10.3748/wjg.v18.i17.2076.
[14] Horii T, Koike T, Abe Y, et al. Two distinct types of cancer of different origin may be mixed in gastroesophageal junction adenocarcinomas in Japan: evidence from direct evaluation of gastric acid secretion [J]. Scand J Gastroenterol, 2011, 46(6):710-719. DOI: 10.3109/00365521.2011.565069.
[15] Uedo N, Yoshio T, Yoshinaga S, et al. Endoscopic gastric mucosal atrophy distinguishes the characteristics of superficial esophagogastric junction adenocarcinoma [J]. Dig Endosc, 2017, 29 Suppl 2: 26-36. DOI: 10.1111/den.12849.
[16] Yamada M, Kushima R, Oda I, et al. Different histological status of gastritis in superficial adenocarcinoma of the esophagogastric junction [J]. Jpn J Clin Oncol, 2014, 44(1):65-71. doi: 10.1093/jjco/hyt167.
[17] 张玲,邹多武. 胃食管反流病的流行病学及危险因素[J]. 临床荟萃,2017,32(1):1-4. DOI:10.3969/j.issn.1004-583X.2017.01.001.
[18] Wang K, Yang CQ, Duan LP, et al. Changing pattern of adenocarcinoma of the esophagogastric junction in recent 10 years: experience at a large tertiary medical center in China[J]. Tumori, 2012,98(5):568-574. DOI: 10.1700/1190.13196.
[19] Keeney S, Bauer TL. Epidemiology of adenocarcinoma of the esophagogastric junction [J]. Surg Oncol Clin N Am, 2006, 15(4):687-696. DOI: 10.1016/j.soc.2006.07.014.
[20] Pandeya N, Webb PM, Sadeghi S, et al. Gastro-oesophageal reflux symptoms and the risks of oesophageal cancer: are the effects modified by smoking, NSAIDs or acid suppressants?[J]. Gut, 2010, 59(1):31-38. DOI: 10.1136/gut.2009.190827.
[21] 张万岱,胡伏莲,萧树东,等. 中国自然人群幽门螺杆菌感染的流行病学调查[J]. 现代消化及介入诊疗,2010,15(5):265-270. DOI:10.3969/j.issn.1672-2159.2010.05.001.
[22] de Martel C, Ferlay J, Franceschi S, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis [J]. Lancet Oncol, 2012, 13(6):607-615. DOI: 10.1016/S1470-2045(12)70137-7.
[23] 王洪斌,李婷,李颖,等. 幽门螺杆菌致癌机制的研究进展[J]. 胃肠病学,2009,14(8):505-507. DOI:10.3969/j.issn.1008-7125.2009.08.016.
[24] Xie S, Wang S, Xue L, et al. Helicobacter pylori is associated with precancerous and cancerous lesions of the gastric cardia mucosa: results of a large population-based study in China [J]. Front Oncol, 2020, 10:205. DOI: 10.3389/fonc.2020.00205.
[25] Wang Y, Liu S, Zhang Y, et al. Helicobacter pylori infection and gastric cardia cancer in Chaoshan region [J]. Microbes Infect, 2014, 16(10):840-744. DOI: 10.1016/j.micinf.2014.06.009.
[26] Kamangar F, Dawsey SM, Blaser MJ, et al. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity [J]. J Natl Cancer Inst, 2006, 98(20):1445-1452. DOI: 10.1093/jnci/djj393.
[27] Ackermark P, Kuipers EJ, Wolf C, et al. Colonization with cagA-positive Helicobacter pylori strains in intestinal metaplasia of the esophagus and the esophagogastric junction [J]. Am J Gastroenterol, 2003, 98(8): 1719-1724. DOI: 10.1111/j.1572-0241.2003.07585.x.
[28] Li SD, Mobarhan S. Association between body mass index and adenocarcinoma of the esophagus and gastric cardia [J]. Nutr Rev, 2000, 58(2 Pt 1): 54-56. DOI: 10.1111/j.1753-4887.2000.tb07811.x.
[29] 陈志峰,侯俊,贺宇彤,等. 体质指数与贲门腺上皮内瘤变和早期贲门癌关系分析[J]. 中国肿瘤临床,2008,35(13):721-724. DOI:10.3969/j.issn.1000-8179.2008.13.001.
[30] Du X, Hidayat K, Shi BM. Abdominal obesity and gastroesophageal cancer risk: systematic review and meta-analysis of prospective studies [J]. Biosci Rep, 2017, 37(3):BSR20160474. DOI: 10.1042/BSR20160474.
[31] Klopp AH, Zhang Y, Solley T, et al. Omental adipose tissue-derived stromal cells promote vascularization and growth of endometrial tumors[J]. Clin Cancer Res, 2012,18(3):771-782. DOI: 10.1158/1078-0432.CCR-11-1916.
[32] Cook MB, Kamangar F, Whiteman DC, et al. Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium [J]. J Natl Cancer Inst, 2010, 102(17): 1344-1353. DOI: 10.1093/jnci/djq289.
[33] Smit CF, Copper MP, van Leeuwen JA, et al. Effect of cigarette smoking on gastropharyngeal and gastroesophageal reflux[J]. Ann Otol Rhinol Laryngol, 2001, 110(2):190-193. DOI: 10.1177/000348940111000216.
[34] Corley DA, Kubo A, Zhao W. Abdominal obesity and the risk of esophageal and gastric cardia carcinomas[J]. Cancer Epidemiol Biomarkers Prev, 2008, 17(2):352-358. DOI: 10.1158/1055-9965.EPI-07-0748.
[35] 曹智博,赵治国,申民强,等. 胃食管结合部早期癌53例内镜特征分析[J]. 中华消化内镜杂志,2016,33(9):603-608. DOI:10.3760/cma.j.issn.1007-5232.2016.09.007.
[36] 徐林生. NBI内镜与常规白光内镜对早期胃癌的诊断价值比较[J]. 现代消化及介入诊疗,2019,24(12):1468-1470. DOI:10.3969/j.issn.1672-2159.2019.12.028.
[37] Kubo A, Corley DA. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis[J]. Cancer Epidemiol Biomarkers Prev, 2006,15(5):872-878. DOI: 10.1158/1055-9965.EPI-05-0860.
[38] Kim JK, Kim GH, Lee BE, et al. Endoscopic submucosal dissection for esophagogastric junction tumors: a single-center experience [J]. Surg Endosc, 2018, 32(2): 760-769. DOI: 10.1007/s00464-017-5735-2.
[39] Park CH, Kim EH, Kim HY, et al. Clinical outcomes of endoscopic submucosal dissection for early stage esophagogastric junction cancer: a systematic review and meta-analysis [J]. Dig Liver Dis, 2015, 47(1):37-44. DOI: 10.1016/j.dld.2014.10.011.
|